ALK (ALKB/ OMX: ALK B / AKABY / AKBLF), a Denmark based provider of allergy prevention, diagnosis and treatment, announced on Monday that it has received U.S. FDA approval for its new line of AccuTest Allergy Skin Testing Devices, designed to enhance the accuracy and reliability of allergy testing and diagnosis.
This product line includes single-prick and multi-head devices, AccuTest-1, AccuTest-8 and AccuTest-10, as well as allergen well trays, aimed at improving diagnostic precision and patient comfort.
The multi-head applicators, available in 8-head and 10-head configurations, offer ergonomic designs with ribbed grips and larger top surface areas for more uniform pressure application, contributing to consistent results. The single-prick device, AccuTest-1, and the multi-head models feature smaller tines to improve accuracy and minimize discomfort.
AccuTest allergen well trays, compatible with the devices, feature a non-slip base and air-tight locking mechanism to prevent contamination, ensuring stability and accuracy during testing.
A recent study highlighted the AccuTest line's precision and its potential to reduce device variability, which could improve the reliability of allergy test results.
ICU Medical establishes JV with Otsuka Pharmaceutical Factory
FDA Panel supports IceCure's ProSense Cryoablation for early-stage breast cancer
Naitive Technologies enters strategic agreement with Parvizi Surgical Innovation
Akura Medical's application for trial of Katana Thrombectomy System receives US FDA approval
Amphix Bio receives USD1m SBIR Phase II grant from National Science Foundation
PharmaNutra signs agreement with strategic consulting firm for US development plan
BD launches advanced Intraosseous Vascular Access System for rapid emergency use
Pulsenmore to supply 25,000 home ultrasound devices to Clalit Health Services
Medtronic announces new, long-term data from SPYRAL HTN-ON MED clinical trial
Senzime unveils next-gen TetraGraph TOF monitor at ANESTHESIOLOGY 2024; US shipments to begin in Q4
Abbott launches new clinical trial to improve results in patients with advanced heart failure
United Therapeutics reaches milestone with 500th lung transplant via ex vivo lung perfusion service
Adocia patents stable hormone combinations for obesity and diabetes
GE HealthCare expands AI-enabled enterprise imaging with Blackford integration